Adrenergic receptor stimulation attenuates insulin-stimulated glucose uptake in 3T3-L1 adipocytes by inhibiting GLUT4 translocation

American Journal of Physiology - Endocrinology and Metabolism

Volumn 289, Issue 4 52-4, 2005, Pages

  Mulder, Alexandra H ^a   Tack, Cees J ^a   Olthaar, André J ^a   Smits, Paul ^a   Sweep, Fred C G J ^a   Bosch, Remko R ^a,b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Catecholamines; Glucose transporter 4

Indexed keywords

1 (2 ETHYLPHENOXY) 3 (1,2,3,4 TETRAHYDRO 1 NAPHTHYLAMINO) 2 PROPANOL OXALATE; 3 ISOPROPYLAMINO 1 (7 METHYL 4 INDANYLOXY) 2 BUTANOL; ADRENALIN; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; BETA 2 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; BETA 3 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CATECHOLAMINE; DEOXYGLUCOSE; GLUCOSE; GLUCOSE TRANSPORTER 1; GLUCOSE TRANSPORTER 4; INSULIN; METOPROLOL; NORADRENALIN; PHENTOLAMINE; PROPRANOLOL;

ADIPOCYTE; ADRENERGIC STIMULATION; ADRENERGIC SYSTEM; ANIMAL CELL; ARTICLE; CELL CULTURE; CELL MEMBRANE; CELL STRAIN 3T3; CENTRIFUGATION; CONTROLLED STUDY; CULTURE MEDIUM; GLUCOSE TRANSPORT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN TRANSPORT; WESTERN BLOTTING;

3T3-L1 CELLS; ADIPOCYTES; ADRENERGIC BETA-AGONISTS; ANIMALS; CATECHOLAMINES; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUCOSE; GLUCOSE TRANSPORTER TYPE 4; INSULIN; MICE; MONOSACCHARIDE TRANSPORT PROTEINS; MUSCLE PROTEINS; PROTEIN TRANSPORT; RECEPTORS, ADRENERGIC, BETA;

EID: 25144493574     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.00079.2004     Document Type: Article

References (39)

1. Bosch RR, Bazuine M, Wake MM, Span PN, Olthaar AJ, Schurmann A, Maassen JA, Hermus AR, Willems PH, and Sweep CG. Inhibition of protein kinase CbetaII increases glucose uptake in 3T3-L1 adipocytes through elevated expression of glucose transporter 1 at the plasma membrane. Mol Endocrinol 17: 1230-1239, 2003.
2. Chang AM and Halter JB. Aging and insulin secretion. Am J Physiol Endocrinol Metab 284: E7-E12, 2003.
3. Chiasson JL, Shikama H, Chu DT, and Exton JH. Inhibitory effect of epinephrine on insulin-stimulated glucose uptake by rat skeletal muscle. J Clin Invest 68: 706-713, 1981.
4. DeFronzo RA and Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 14: 173-194, 1991.
5. Green A, Carroll RM, and Dobias SB. Desensitization of beta-adrenergic receptors in adipocytes causes increased insulin sensitivity of glucose transport. Am J Physiol Endocrinol Metab 271: E271-E276, 1996.
6. Hunt DG, Ding Z, and Ivy JL. Clenbuterol prevents epinephrine from antagonizing insulin-stimulated muscle glucose uptake. J Appl Physiol 92: 1285-1292, 2002.
7. Hunt DG, Ding Z, and Ivy JL. Propranolol prevents epinephrine from limiting insulin-stimulated muscle glucose uptake during contraction. J Appl Physiol 93: 697-704, 2002.
8. Hunt DG and Ivy JL. Epinephrine inhibits insulin-stimulated muscle glucose transport. J Appl Physiol 93: 1638-1643, 2002.
9. Jamerson KA, Julius S, Gudbrandsson T, Andersson O, and Brant DO. Reflex sympathetic activation induces acute insulin resistance in the human forearm. Hypertension 21: 618-623, 1993.
10. James DE, Hiken J, and Lawrence JC Jr. Isoproterenol stimulates phosphorylation of the insulin-regulatable glucose transporter in rat adipocytes. Proc Natl Acad Sci USA 86: 8368-8372, 1989.
11. Joost HG, Weber TM, Cushman SW, and Simpson IA. Insulin-stimulated glucose transport in rat adipose cells. Modulation of transporter intrinsic activity by isoproterenol and adenosine. J Biol Chem 261: 10033-10036, 1986.
12. Joost HG, Weber TM, Cushman SW, and Simpson IA. Activity and phosphorylation state of glucose transporters in plasma membranes from insulin-, isoproterenol-, and phorbol ester-treated rat adipose cells. J Biol Chem 262: 11261-11267, 1987.
13. 3-adrenoceptor-deficient brown adipocytes. Am J Physiol Endocrinol Metab 283: E146-E153, 2002.
14. Kashiwagi A, Huecksteadt TP, and Foley JE. The regulation of glucose transport by cAMP stimulators via three different mechanisms in rat and human adipocytes. J Biol Chem 258: 13685-13692, 1983.
15. Kirsch DM, Baumgarten M, Deufel T, Rinninger F, Kemmler W, and Haring HU. Catecholamine-induced insulin resistance of glucose transport in isolated rat adipocytes. Biochem J 216: 737-745, 1983.
16. Klein J, Fasshauer M, Ito M, Lowell BB, Benito M, and Kahn CR. Beta(3)-adrenergic stimulation differentially inhibits insulin signaling and decreases insulin-induced glucose uptake in brown adipocytes. J Biol Chem 274: 34795-34802, 1999.
17. Kuroda M, Honnor RC, Cushman SW, Londos C, and Simpson IA. Regulation of insulin-stimulated glucose transport in the isolated rat adipocyte. cAMP-independent effects of lipolytic and antilipolytic agents. J Biol Chem 262: 245-253, 1987.
18. Lawrence JC Jr, Hiken JF, and James DE. Phosphorylation of the glucose transporter in rat adipocytes. Identification of the intracellular domain at the carboxyl terminus as a target for phosphorylation in intact-cells and in vitro. J Biol Chem 265: 2324-2332, 1990.
19. Lee AD, Hansen PA, Schluter J, Gulve EA, Gao J, and Holloszy JO. Effects of epinephrine on insulin-stimulated glucose uptake and GLUT-4 phosphorylation in muscle. Am J Physiol Cell Physiol 273: C1082-C1087, 1997.
20. Lefrere I, De Coppet P, Camelin JC, Le Lay S, Mercier N, Elshourbagy N, Bril A, Berrebi-Bertrand I, Feve B, and Krief S. Neuropeptide AF and FF modulation of adipocyte metabolism. Primary insights from functional genomics and effects on beta-adrenergic responsiveness. J Biol Chem 277: 39169-39178, 2002.
21. Lembo G, Capaldo B, Rendina V, Iaccarino G, Napoli R, Guida R, Trimarco B, and Sacca L. Acute noradrenergic activation induces insulin resistance in human skeletal muscle. Am J Physiol Endocrinol Metab 266: E242-E247, 1994.
22. Mark AL. The sympathetic nervous system: contribution to human hypertension and related cardiovascular diseases. J Hypertens 14 Suppl: S159-S165, 1996.
23. Moberg E, Kollind M, Lins PE, and Adamson U. Acute mental stress impairs insulin sensitivity in IDDM patients. Diabetologia 37: 247-251, 1994.
24. Ng AV, Callister R, Johnson DG, and Seals DR. Age and gender influence muscle sympathetic nerve activity at rest in healthy humans. Hypertension 21: 498-503, 1993.
25. Nishimura H, Saltis J, Habberfield AD, Garty NB, Greenberg AS, Cushman SW, Londos C, and Simpson IA. Phosphorylation state of the GLUT4 isoform of the glucose transporter in subfractions of the rat adipose cell: effects of insulin, adenosine, and isoproterenol. Proc Natl Acad Sci USA 88: 11500-11504, 1991.
26. Piascik MT and Perez DM. Alpha1-adrenergic receptors: new insights and directions. J Pharmacol Exp Ther 298: 403-410, 2001.
27. Piper RC, James DE, Slot JW, Puri C, and Lawrence JC Jr. GLUT4 phosphorylation and inhibition of glucose transport by dibutyryl cAMP. J Biol Chem 268: 16557-16563, 1993.
28. Reusch JE, Sussman KE, and Draznin B. Inverse relationship between GLUT4 phosphorylation and its intrinsic activity. J Biol Chem 268: 3348-3351, 1993.
29. Rockman HA, Koch WJ, and Lefkowitz RJ. Seven-transmembrane-spanning receptors and heart function. Nature 415: 206-212, 2002.
30. Sakoda H, Ogihara T, Anai M, Funaki M, Inukai K, Katagiri H, Fukushima Y, Onishi Y, Ono H, Fujishiro M, Kikuchi M, Oka Y, and Asano T. Dexamethasone-induced insulin resistance in 3T3-L1 adipocytes is due to inhibition of glucose transport rather than insulin signal transduction. Diabetes 49: 1700-1708, 2000.
31. Scherrer U, Randin D, Tappy L, Vollenweider P, Jequier E, and Nicod P. Body fat and sympathetic nerve activity in healthy subjects. Circulation 89: 2634-2640, 1994.
32. Schurmann A, Monden I, Joost HG, and Keller K. Subcellular distribution and activity of glucose transporter isoforms GLUT1 and GLUT4 transiently expressed in COS-7 cells. Biochim Biophys Acta 1131: 245-252, 1992.
33. Shepherd PR, Withers DJ, and Siddle K. Phosphoinositide 3-kinase: the key switch mechanism in insulin signalling. Biochem J 333: 471-490, 1998.
34. Smith U, Kuroda M, and Simpson IA. Counter-regulation of insulin-stimulated glucose transport by catecholamines in the isolated rat adipose cell. J Biol Chem 259: 8758-8763, 1984.
35. Tanishita T, Shimizu Y, Minokoshi Y, and Shimazu T. The beta3-adrenergic agonist BRL37344 increases glucose transport into L6 myocytes through a mechanism different from that of insulin. J Biochem (Tokyo) 122: 90-95, 1997.
36. Thomson MJ, Williams MG, and Frost SC. Development of insulin resistance in 3T3-L1 adipocytes. J Biol Chem 272: 7759-7764, 1997.
37. Van Putten JP and Krans HM. Long-term regulation of hexose uptake by isoproterenol in cultured 3T3 adipocytes. Am J Physiol Endocrinol Metab 248: E706-E711, 1985.
38. Vannucci SJ, Nishimura H, Satoh S, Cushman SW, Holman GD, and Simpson IA. Cell surface accessibility of GLUT4 glucose transporters in insulin-stimulated rat adipose cells. Modulation by isoprenaline and adenosine. Biochem J 288: 325-330, 1992.
39. Wu-Wong JR, Berg CE, and Dayton BD. Endothelin-stimulated glucose uptake: effects of intracellular Ca(2+), cAMP and glucosamine. Clin Sci (Lond) 103, Suppl 48: 418S-423S, 2002.